November Newsletter

Group K Diagnostic’s focus is to create a cost and time-effective point-of-care diagnostic solution.  Though it may have gotten colder in Philadelphia, we're warming up with some new discoveries and partnerships as well as the start of our clinical trials.  If you haven't signed up before, we'd like to invite you to continue to follow us by clicking the subscribe button.

Thanks for joining!

Here at Group K, we've awaited clinical trials and the expansion of our diagnostic pipeline over the last year.  After we receive IRB approval, we are excited to announce that we will begin our first manufacturing run specifically for clinical trials.  We've also expanded our diagnostic pipeline to include a research partnership to bring a point of care liver cancer diagnostic to the market, and started on chemistry metabolic panel research. 

Emilia Lopez-Ona